We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+12.16%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$718B
AUM Growth
+$49.7B
Cap. Flow
-$15.6B
Cap. Flow %
-2.17%
Top 10 Hldgs %
31.75%
Holding
3,044
New
123
Increased
1,636
Reduced
968
Closed
150

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$3.11B
2
META icon
Meta Platforms (Facebook)
META
+$2.59B
3
EQT icon
EQT Corp
EQT
+$1.31B
4
CL icon
Colgate-Palmolive
CL
+$1.08B
5
ADBE icon
Adobe
ADBE
+$1.06B

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.92B
2
UNH icon
UnitedHealth
UNH
+$1.78B
3
AMD icon
Advanced Micro Devices
AMD
+$1.55B
4
ROST icon
Ross Stores
ROST
+$1.54B
5
ASML icon
ASML
ASML
+$1.49B

Sector Composition

Rank Sector Weight
1 Technology 31.61%
2 Healthcare 16.91%
3 Consumer Discretionary 11.05%
4 Financials 10.6%
5 Communication Services 9.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOTE
2801
DELISTED
FiscalNote
NOTE
$47K ﹤0.01%
+1,055
New +$29.6K
NRDY icon
2802
Nerdy
NRDY
$93.7M
$47K ﹤0.01%
11,044
+513
+5% +$1.82K
CSSE
2803
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$47K ﹤0.01%
39,100
+12,800
+49% +$19.8K
SRTA
2804
Strata Critical Medical Inc
SRTA
$533M
$46K ﹤0.01%
11,567
+676
+6% +$2.15K
CRBU icon
2805
Caribou Biosciences
CRBU
$169M
$45K ﹤0.01%
10,546
SB icon
2806
Safe Bulkers
SB
$760M
$45K ﹤0.01%
13,775
GTHX
2807
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$45K ﹤0.01%
17,755
BHIL
2808
DELISTED
Benson Hill, Inc.
BHIL
$45K ﹤0.01%
970
+36
+4% +$1.54K
HLLY icon
2809
Holley
HLLY
$384M
$44K ﹤0.01%
10,697
+559
+6% +$1.67K
DNMR
2810
DELISTED
Danimer Scientific, Inc.
DNMR
$44K ﹤0.01%
456
+40
+10% +$5.13K
ERAS icon
2811
Erasca
ERAS
$6.5B
$43K ﹤0.01%
15,457
+829
+6% +$2.36K
PHUN icon
2812
Phunware
PHUN
$43M
$43K ﹤0.01%
1,572
STIM icon
2813
Neuronetics
STIM
$223M
$42K ﹤0.01%
19,100
POWW icon
2814
Outdoor Holding Co
POWW
$267M
$41K ﹤0.01%
18,996
+3,020
+19% +$5.9K
AKTS
2815
DELISTED
Akoustis Technologies Inc
AKTS
$41K ﹤0.01%
12,783
VLD
2816
DELISTED
Velo3D, Inc.
VLD
$41K ﹤0.01%
534
+216
+68% +$15.1K
OVID icon
2817
Ovid Therapeutics
OVID
$489M
$40K ﹤0.01%
12,113
-15,387
-56% -$52.2K
FUV
2818
DELISTED
Arcimoto, Inc. Common Stock
FUV
$40K ﹤0.01%
26,725
NAUT icon
2819
Nautilus Biotechnolgy
NAUT
$114M
$39K ﹤0.01%
+10,012
New +$28.8K
NKTR icon
2820
Nektar Therapeutics
NKTR
$2.57B
$39K ﹤0.01%
4,443
-14,735
-77% -$157K
POL
2821
DELISTED
Polished.com Inc.
POL
$39K ﹤0.01%
1,685
NN icon
2822
NextNav
NN
$3.25B
$38K ﹤0.01%
12,764
+692
+6% +$1.67K
SRT
2823
DELISTED
Startek Inc.
SRT
$38K ﹤0.01%
12,800
ADV icon
2824
Advantage Solutions
ADV
$399M
$37K ﹤0.01%
630
+27
+4% +$1.16K
INO icon
2825
Inovio Pharmaceuticals
INO
$79.6M
$37K ﹤0.01%
6,792
-3,722
-35% -$30K

Similar funds

T. Rowe Price Associates's Q2 2023 Portfolio in Review

As of Q2 2023, T. Rowe Price Associates held 3,044 positions worth $718B, up 7.4% from $668B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

T. Rowe Price Associates's Q2 2023 filing shows 123 new, 1,636 increased, 968 reduced and 150 closed positions. Its largest new stake was Kenvue: 26,317,608 shares worth $695M. The largest sale was Microsoft, an estimated $1.92B.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2023 buy was Kenvue: 26,317,608 shares worth $695M.
  • T. Rowe Price Associates added most to Amazon in Q2 2023, an estimated $3.11B increase.
  • T. Rowe Price Associates's biggest Q2 2023 reduction was Microsoft, cutting an estimated $1.92B.
  • T. Rowe Price Associates fully exited Canadian Natural Resources in Q2 2023, selling an estimated $112M.
  • T. Rowe Price Associates's ten largest holdings make up 32% of its $718B portfolio in Q2 2023.
  • T. Rowe Price Associates opened 123 new positions and closed 150 in Q2 2023.
  • T. Rowe Price Associates's portfolio value rose 7.4% quarter-over-quarter to $718B.

Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.